Dexpak Jr Taperpak Oral Tablet 1.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

DexPak Jr TaperPak: Oral tablet (1.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_12535.JPG
Zema-Pak 10-day TaperPak Tab
Macoven Pharmaceuticals, LLC
Pill Identification: 54 943 
Drug Image file DrugItem_6448.JPG
Dexamethasone 1.5mg Tab
Roxane Laboratories Inc
Pill Identification: 54 943 
Drug Image file DrugItem_11347.JPG
DexPak 10-day TaperPak Tab
ECR Pharmaceuticals
Pill Identification: 54 943 
Drug Image file DrugItem_8168.JPG
DexPak 10-day TaperPak Tab
ECR Pharmaceuticals
Pill Identification: 54 943 
Drug Image file DrugItem_12660.JPG
Zema-Pak 6-day TaperPak Tab
Macoven Pharmaceuticals, LLC
Pill Identification: 54 943 
Drug Image file DrugItem_498.JPG
Dexamethasone 1.5mg Tab
Par Pharmaceutical Inc
Pill Identification: par 086 
Drug Image file DrugItem_21169.JPG
Dexamethasone 1.5mg Tab
Par Pharmaceutical Inc
Pill Identification: par 086 
Drug Image file DrugItem_12537.JPG
Zema-Pak 13-day TaperPak
Macoven Pharmaceuticals, LLC
Pill Identification: 54 943 
Drug Image file DrugItem_6447.JPG
Dexamethasone 1.5mg Tab
Roxane Laboratories Inc
Pill Identification: 54 943 
Drug Image file DrugItem_8167.JPG
DexPak 13-day TaperPak
ECR Pharmaceuticals
Pill Identification: 54 943,par 086 

What is this Medicine?

DEXAMETHASONE (dex a METH a sone) is a corticosteroid. It is commonly used to treat inflammation of the skin, joints, lungs, and other organs. Common conditions treated include asthma, allergies, and arthritis. It is also used for other conditions, such as blood disorders and diseases of the adrenal glands.

In-Depth Information

DexPak 10-day TaperPak 1.5mg Tablet

NDC: 000950086
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma, Tenosynovitis, Tuberculosis Infection, Systemic Lupus Erythematosus (SLE), Pneumonitis, Giant Papillary Conjunctivitis (GPC), Adrenocortical Insufficiency, Proteinuria, Crohn's Disease, Congenital Adrenal Hyperplasia, Vernal Keratoconjunctivitis, Rheumatoid Arthritis, Adrenogenital Syndrome, Nephrotic Syndrome, Rheumatic Carditis, Idiopathic Thrombocytopenic Purpura (ITP), Pruritus, Allergic Conjunctivitis, Angioedema, Serum Sickness, Graves' Ophthalmopathy, Cerebral Edema, Hypothalamic-pituitary-adrenal (HPA) Suppression Diagnosis, Addison's Disease, Iritis, Trichinosis, Dermatomyositis, Ankylosing Spondylitis, Herpes Zoster Ocular Infection, Chronic Obstructive Pulmonary Disease (COPD), Anterior Segment Inflammation, Berylliosis, Anaphylaxis, Anaphylactic Shock, Non-Hodgkin's Lymphoma (NHL), Acute Lymphocytic Leukemia (ALL), Postoperative Ocular Inflammation, Loeffler's Syndrome, Bursitis, Epicondylitis, Stevens-Johnson Syndrome, Corneal Ulcer, Corneal Abrasion, Asthma, Hypoplastic Anemia, Ulcerative Colitis, Keratitis, Chorioretinitis, Myasthenia Gravis, Sarcoidosis, Osteoarthritis, Polymyositis, Gouty Arthritis, Thyroiditis, Thrombocytopenia, Psoriatic Arthritis, Multiple Sclerosis, Hodgkin's Disease, Juvenile Rheumatoid Arthritis (JRA)/juvenile Idiopathic Arthritis (JIA), Hemolytic Anemia, Optic Neuritis, Erythroblastopenia, Hypercalcemia

Sometimes used for but not FDA approved for the following conditions:
Bronchiolitis, Temporal Arteritis, Altitude Sickness, Meningitis, Altitude Sickness Prophylaxis, Spinal Cord Compression, Pulmonary Edema, Mixed Connective Tissue Disease, Infertility, Pseudogout, Endophthalmitis, Wegener's Granulomatosis, Laryngotracheobronchitis (croup), Chemotherapy-induced Nausea/vomiting, Polychondritis, Chemotherapy-induced Nausea/vomiting Prophylaxis, Chronic Lung Disease (CLD), Polyarteritis Nodosa, Churg-Strauss Syndrome

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
DexPak 10-day TaperPak 1.5mg Tablet
Drug Image file DrugItem_11347.JPG
ECR Pharmaceuticals
Pill Identification: 54 943 
Shape: round
Color: pink
Drug Image file DrugItem_8168.JPG
ECR Pharmaceuticals
Pill Identification: 54 943 
Shape: round
Color: pink

Reported Side Effects for DexPak 10-day TaperPak 1.5mg Tablet

Headache Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for DexPak 10-day TaperPak 1.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and DexPak 10-day TaperPak 1.5mg Tablet(Dexamethasone)
Marijuana and Dexamethasone(Dexamethasone)
Dexamethasone can theoretically increase the elimination of Marijuana, Medical from the body. The side effects profile of Marijuana, Medical may be altered if you take Dexamethasone. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with DexPak Jr TaperPak

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5